Southeast Asia's Digital Health Revolution Accelerates as HIMSS25 APAC Launches in Malaysia

July 16, 2025 11:30 AM

Global healthcare luminaries converge this week at HIMSS25 APAC in Kuala Lumpur, where Black Book Research unveils pioneering insights on Southeast Asia's meteoric rise as an epicenter for digital health innovation. This new market intelligence charts an ecosystem fueled by platform convergence, population health analytics, and intelligent care delivery, driven by leading-edge strategies in Malaysia, Singapore, Thailand, Indonesia, and...

Read more

Boise Urologist Dr. Austen Slade Hosts Leading Physicians for Advanced Surgical Training

July 16, 2025 11:00 AM

The HoLEP procedure, a minimally invasive treatment for benign prostatic hyperplasia (BPH), is recognized for its effectiveness, reduced recovery time, and lower complication rates compared to traditional methods. Dr. Slade's expertise in this technique has positioned him as a national expert and key resource for urologists across the country seeking to enhance their skills in this innovative approach. Recognizing his expertise, patients from...

Read more

New Peer-Reviewed Study Reveals Severe Health and Economic Consequences of 2025 Medicaid Policy Changes

July 16, 2025 11:00 AM

Waymark, a public benefit company dedicated to improving access and quality of care in Medicaid, today published peer-reviewed research in JAMA Health Forum examining the projected health system and economic impacts of 2025 Medicaid policy changes. The study, conducted in collaboration with researchers at the University of North Carolina at Chapel Hill, reveals that H.R. 1, the "One Big Beautiful Bill Act" recently passed by Congress, could...

Read more

HIMSS25 APAC Highlights Surge in Population Health Tech Adoption Across Asia-Pacific, Recognizes Regional Leaders in Digital Health Innovation

July 16, 2025 10:30 AM

As HIMSS25 APAC convenes healthcare leaders, innovators, and policymakers in Kuala Lumpur this week, a major spotlight is cast on the dramatic rise of Population Health Management (PHM) adoption across the Asia-Pacific region. According to the newly released Q3 2025 Black Book of Global Healthcare IT, Asia-Pacific is projected to account for 33% of global PHM market growth, reaching an estimated USD 90 billion by 2031.This growth is being driven...

Read more

Phase 1 Equity Announces It's Fourth Practice Addition Of The Year, Bringing On Another Multi-Site and Multi-Doctor Orthodontic Practice Located in Pennsylvania

July 16, 2025 10:00 AM

Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site and multi-doctor orthodontic practice based in Pennsylvania to its growing network.Known for delivering exceptional, patient-centered care - from advanced 3D imaging to a full spectrum of treatment options - this multi-location practice reflects a strong culture of innovation,...

Read more

CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC")

July 16, 2025 9:15 AM

CS Diagnostics Corp. (OTCQB:CSDX) is pleased to announce that it has successfully submitted the final draft of Form F-10 registration statement with the Processing Team for Edgarization and filing with United States Securities and Exchange Commission ("SEC")This significant milestone marks a key step forward in the company's strategic plan to regulate its presence in the market. Submitting Form F-10 enhances investor confidence through greater...

Read more

Dr. Ashish Shah Joins Ankle & Foot Centers of America, Serving Patients in Buckhead and Marietta

July 16, 2025 9:00 AM

Ankle & Foot Centers of America is pleased to welcome Dr. Ashish Shah to its team of foot and ankle specialists. A highly trained and compassionate podiatric physician, Dr. Shah will serve patients at the practice's Buckhead and Marietta (Windy Hill) offices.Founded in 1982, Ankle & Foot Centers of America is one of the country's leading podiatry practices, with more than 40 locations across Georgia. Its team of board-certified physicians...

Read more

New Study Reveals Independent Physician Practices Deliver Better Outcomes at Lower Cost in Chicago's Healthcare Market

July 16, 2025 9:00 AM

Medicare beneficiaries treated by physicians in the medical group that is part of Duly Health and Care, the largest independent multi-specialty physician practice in the Midwest, posted total Medicare expenditures in 2023 that were nearly $7,800 lower on average than their peers treated by hospital-affiliated physicians.That's among the key findings of "Health System Consolidation and Employer/Payer Considerations," a new study of Chicago's...

Read more

130,000 Clinicians, 15 Years of Insights: Black Book Surveys Reveal Major Advances in EHR Usability and Clinician Satisfaction

July 16, 2025 9:00 AM

Fourteen years after the first major wave of hospital Electronic Health Record (EHR) adoption, Black Book Research's latest clinician insights confirm a transformative shift in digital health experiences. Black Book polling derived directly from nearly 130,000 hospital-based clinicians since 2011 reveals significant advancements in EHR usability, workflow integration, and overall clinician satisfaction. These enhancements have emerged not from...

Read more

Glioblastoma Foundation Launches Gliolab, Offering Three Cutting-Edge Genomic Tests to Deliver a Personalized Treatment Roadmap for Every Glioblastoma Patient

July 16, 2025 9:00 AM

On Glioblastoma Awareness Day, the Glioblastoma Foundation proudly announces the official launch of Gliolab, a CLIA-certified genomic testing laboratory dedicated exclusively to glioblastoma. Gliolab will offer three state-of-the-art genomic tests that together provide a personalized treatment roadmap for every patient diagnosed with this aggressive brain cancer, transforming care and access for thousands of families.In a healthcare environment...

Read more

Cantargia Announces Publication of Clinical Data Showing Benefit of Nadunolimab Combination Therapy in Advanced Lung Cancer

July 16, 2025 8:30 AM

LUND, SE / ACCESS Newswire / July 16, 2025 / Cantargia (STO:CANTA)Promising efficacy data with median PFS of 7.2 months (95%CI 5.6-9.2), median OS of 13.7 months (95%CI 11.1-18.3), and 1-year survival of 54%Strong efficacy signal observed in non-squamous NSCLC patients previously treated with the PD-1 inhibitor pembrolizumab, with median OS of 26.7 months and 91% ORR, including two complete responsesCantargia (Cantargia AB; Nasdaq Stockholm:...

Read more

WHO Extended Global Emergency Status of MPox Epidemic - Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides

July 16, 2025 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, comments on the extension of the MPox Public Health Emergency of International Concern (PHEIC) by WHO.The Director General of WHO has extended the PHEIC declaration for MPox epidemic according to a...

Read more

Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026

July 16, 2025 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization, today announced it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The compliance confirmation comes as Ainos gains momentum across its AI Nose platform, with strategic deployments, commercial partnerships, and a 90-day execution plan aimed at enabling large-scale...

Read more

Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse

July 16, 2025 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering novel solutions for severe pain with built-in abuse and overdose protection, today announced the initiation of its pivotal Phase 3 study of PF614, the Company's lead product candidate.This landmark study, PF614-301, ‘A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and...

Read more

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets

July 16, 2025 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for companion and equine animals, is pleased to announce the next installment of its Fourth Friday at Four webinar series, scheduled for Friday, July 25, 2025 at 4:00 PM ET.This month's session will highlight the Assisi line of products, Zomedica's suite of targeted Pulsed Electromagnetic Field (tPEMF)...

Read more

AlzeCure Receives Additional Subscription Commitments of Approximately SEK 7 million in the Ongoing Rights Issue

July 16, 2025 5:40 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB ("AlzeCure" or the "Company") has received additional subscription commitments of SEK 7 million from a group of qualified investors in the Company's ongoing rights issue announced on June 16, 2025 (the "Rights Issue"). Should the issue be oversubscribed, the Company intends to utilize the remaining portion of the Over-Allotment Option, following the previously announced additional...

Read more

The DEA's BILLION Dollar Marijuana Scandal: A DEA Regulatory Betrayal of Science and Public Trust

July 16, 2025 5:00 AM

For nearly a decade, the U.S. Drug Enforcement Administration (DEA) claimed it was committed to expanding scientific research into marijuana. What it delivered instead was a sweeping, systemic fraud-an elaborate shell game that misled scientists, investors, patients, and Congress. Behind the curtain: a campaign of obstruction, regulatory sabotage, and financial deceit that enabled scams, destroyed real innovation, and shielded a broken...

Read more

Hemogenyx Awarded Grant

July 16, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has been awarded a $120,000 G-Rex® grant from ScaleReady, in collaboration with Wilson Wolf Manufacturing and Cell Ready (the "Grant"), to support the optimization and scale-up of the manufacturing process for its lead CAR-T product candidate, HG-CT-1, currently in a Phase I clinical trial for relapsed/refractory acute myeloid leukemia (R/R AML) in adults.The Grant will...

Read more

Avant Brands Announces Results for Q2 2025

July 15, 2025 4:30 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today released its financial results for the second quarter ended May 31, 2025 ("Q2 2025"). With a growing international footprint and deep penetration into key global medical markets, Avant continues to scale as the go-to Canadian exporter for top-shelf cannabis at commercial volume. The Company...

Read more

CCA Industries, Inc. Reports Results of Operations for the Quarter and Six Months ended May 31, 2025

July 15, 2025 4:25 PM

CCA Industries, Inc. (OTC:CAWW), announced today its results for the three months and six months ended May 31, 2025. The results can be found in the chart below.The net income was $2,929 for the three months ending May 31, 2025, compared to a loss of $24,421 for the three months ending May 31, 2024. The net income was $16,682 for the six months ending May 31, 2025, compared to a loss of $269,831 for the six months ending May 31, 2024. As shown...

Read more